KI-gestützte Arzneimittelentdeckung: Chinas Biotech-Revolution und globale Auswirkungen

China is making waves in AI-driven drug discovery, with companies like XtalPi helping develop critical medications like Pfizer’s COVID-19 drug Paxlovid. This article explores how China’s biotech sector is leveraging AI to accelerate drug development, potentially saving countless lives. The article explores these critical questions:

1. How will AI reshape the future of medicine and drug discovery globally?
2. What are the risks and benefits of international collaboration in biotech, especially between the US and China?
3. How can we balance national security concerns with the need for scientific progress?
4. Could AI-powered biotech lead to personalized medicine breakthroughs or unforeseen consequences?

Is the convergence of AI and biotech overblown? What do you think the future holds for global health innovation and geopolitics?